- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Bilateral Ovarian Disease
Total 377556 results
-
Nanfang Hospital of Southern Medical UniversityUnknownPrimary Ovarian InsufficiencyChina
-
Assisting NatureUnknownInfertility | Premature Ovarian FailureGreece
-
CanariaBio Inc.Korean Cancer Study GroupRecruitingOvarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer by FIGO StageKorea, Republic of
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedStage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedAdult Type Ovarian Granulosa Cell Tumor | Ovarian Gynandroblastoma | Ovarian Sertoli-Leydig Cell Tumor | Ovarian Sex Cord Tumor With Annular Tubules | Ovarian Steroid Cell TumorUnited States, Japan
-
Cengiz Gokcek Women's and Children's HospitalRecruitingPremature Ovarian FailureTurkey
-
Tanta UniversityCompletedPremature Ovarian FailureEgypt
-
South Valley UniversityTerminatedPremature Ovarian FailureEgypt
-
South Valley UniversityCompletedPremature Ovarian Failure
-
Shenzhen Beike Bio-Technology Co., Ltd.UnknownPremature Ovarian Failure,China
-
Tongji HospitalRecruiting
-
Menoufia UniversityRecruitingOvarian StimulationEgypt
-
The Foundation for Orthopaedics and Regenerative...RecruitingOvarian FailureAntigua and Barbuda
-
Andros Day Surgery ClinicCompleted
-
University Hospital, Basel, SwitzerlandRoche Diagnostic Ltd.CompletedOvarian FailureSwitzerland
-
ART Fertility Clinics LLCTerminatedOvarian HyperstimulationUnited Arab Emirates
-
Tabriz UniversityCompleted
-
Sunnybrook Health Sciences CentreGlaxoSmithKlineRecruitingOvarian Cancer | Stage IV Ovarian Cancer | High Grade Ovarian Serous Adenocarcinoma | Stage III Ovarian CancerCanada
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina
-
MTrap, Inc.MedPass InternationalCompletedOvarian Cancer Stage IIIC | Ovarian Cancer Stage IVSpain
-
Azaya Therapeutics, Inc.UnknownCancer | Ovarian Cancer | Ovarian Epithelial Cancer Recurrent | Malignant Female Reproductive System Neoplasm | Ovarian TumorCanada, United States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Mucinous... and other conditionsUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Serous Cystadenocarcinoma | Ovarian Undifferentiated CarcinomaUnited States
-
University of AarhusCompletedPolycystic Ovarian DiseaseDenmark
-
University of PalermoNot yet recruitingBorderline Ovarian Tumor
-
Peking Union Medical College HospitalZai Lab (Shanghai) Co., Ltd.Not yet recruiting
-
AstraZenecaCompletedRelapsed Ovarian Cancer, BRCA Mutation, Platinum SensitivityUnited States, Canada
-
PharmaMar, SpainCompleted
-
AstraZenecaMyriad Genetic Laboratories, Inc.WithdrawnPlatinum Sensitive Relapsed Ovarian CancerUnited States, Korea, Republic of, Peru, United Kingdom, Philippines
-
Sonitus Medical IncCompletedHearing Loss | Unilateral Hearing Loss | Total Unilateral DeafnessUnited States
-
Biocity Biopharmaceutics Co., Ltd.Not yet recruitingAdvanced Ovarian Cancer | Serous Ovarian Cancer
-
Radboud University Medical CenterRecruitingEpithelial Ovarian Cancer | Ovarian CarcinomaNetherlands
-
Maxima Medical CenterRadboud University Medical Center; Catharina Ziekenhuis Eindhoven; The Netherlands... and other collaboratorsRecruitingOvarian Cancer | Ovarian TumorNetherlands
-
Leiden University Medical CenterRecruitingOvarian Cancer RecurrentNetherlands
-
AGO Research GmbHHoffmann-La RocheActive, not recruitingRecurrent Ovarian CarcinomaNorway, Spain, France, Switzerland, Denmark, Germany, Sweden, Belgium, Finland, Austria, Estonia, Lithuania
-
Tesaro, Inc.Approved for marketingRecurrent Ovarian Cancer
-
University of UtahWithdrawn
-
Zhongda HospitalNot yet recruitingOvarian Cancer, EpithelialChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPlatinum-resistant Recurrent Ovarian CancerChina
-
West China Second University HospitalNot yet recruitingRecurrent Ovarian CancerChina
-
Hospital Clinic of BarcelonaRecruitingAdvanced Ovarian CancerSpain
-
Xinhua Hospital, Shanghai Jiao Tong University...WithdrawnPlatinum-resistant Ovarian CancerChina
-
AstraZenecaEuropean Network of Gynaecological Oncological Trial Groups (ENGOT)CompletedEpithelial Ovarian CancerDenmark, France, Germany, Italy, Spain, Poland, Belgium, Canada, United Kingdom, Israel, Norway
-
The Affiliated Hospital of Qingdao UniversityCompletedHigh-Grade Serous Ovarian CancerChina
-
PsiOxus Therapeutics LtdCompletedRecurrent Platinum Resistant Ovarian CancerUnited Kingdom, Spain
-
Jihong LiuUnknownPlatinum-resistant Ovarian CancerChina
-
Fondazione Policlinico Universitario Agostino Gemelli...UnknownEpithelial Ovarian Cancer
-
Medical University of ViennaCompletedOvarian Epithelial CancerAustria, Germany, Belgium, Czechia
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
Centre Francois BaclesseARCAGY/ GINECO GROUP; French Cancer Research Hospital ProgramCompletedPlatinum-resistant or Refractory Ovarian CancerFrance